Dr. Shruti Murali, MD

  • Rockville, MD
  • Medical oncologist
NPI1902241649PAC ID0042530305
Medicare services, 2024
152,801
Medicare patients, 2024
744
Part D claims, 2024
805
Publications
3
Clinical trials
1
Practice address
9905 Medical Center Way, Rockville, MD 20850
Practice phone
Call (301) 470-1001
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Maryland Oncology Hematology, P.A.

Rockville, Maryland

See all 10 affiliations

Find Dr. Murali's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Shruti Murali is a medical oncologist in Rockville, Maryland

Dr. Murali practices at Maryland Oncology Hematology, P.A. in Rockville, Maryland.

Dr. Murali's NPI, 1902241649, was assigned on May 8, 2013. Dr. Murali holds Maryland license D86774.

NPI and contact details
Medicare PAC ID
0042530305
NPI enumeration date
May 8, 2013
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(301) 470-1001
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
33
Medical school graduation
2019

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Shruti Murali practices at Maryland Oncology Hematology, P.A. in Rockville, Maryland

Dr. Murali's primary practice is Maryland Oncology Hematology, P.A., at 9905 Medical Center Way, Rockville, MD 20850 in Montgomery County. The practice phone is (301) 470-1001.

  • Maryland Oncology Hematology, P.A.
    9905 Medical Center Way, Rockville, MD 20850 · Montgomery CountyPhone(301) 470-1001

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Shruti Murali is affiliated with 8 sites of care and 2 medical groups

Dr. Murali's primary practice is Maryland Oncology Hematology, P.A. in Rockville, Maryland. Dr. Murali is also affiliated with Adventist HealthCare Shady Grove Medical Center. The medical group on file is UM St. Joseph Medical Group. Dmand AI also links Dr. Murali to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

See all 10 affiliations for Dr. Murali

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Shruti Murali's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Murali practices, 7 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Maryland Oncology Hematology, P.A.Available with a free account
+7 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Murali practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Shruti Murali is one of 157 medical oncologists in Maryland

Medical oncology is Dr. Murali's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Murali is licensed in Maryland.

Specialties and state licenses

  • Medical oncology, MarylandPrimaryLicense D86774 · taxonomy 207RX0202X

Medical oncologists near Dr. Murali

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

157medical oncologists in Maryland
6medical oncologists in Rockville

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Shruti Murali billed Medicare for 152,801 services in 2024

CMS data shows 152,801 Medicare services from Dr. Murali across 65 procedure codes in 2024, for 744 Medicare patients. Medicare paid $2,046,193 for them.

Medicare services, 2024152,801
Medicare patients744
Paid by Medicare$2M
Procedure codes65

Dr. Murali's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 120,2982024: 143,93920%
Lab and pathology
2023: 4,3852024: 5,50626%
Tests and treatments
2023: 1,7482024: 2,16424%
Office and hospital visits
2023: 1,1582024: 1,0827%
Other services
2023: 02024: 55
Surgery
2023: 662024: 5517%

Where Dr. Murali's Medicare services took place, 2024

  • In an office152,741100%
  • In a facility600%

Dr. Murali compared with the Maryland median for medical oncologists, 2024

  • Dr. Murali
  • Maryland median
Medicare services
152,801vs 422362.1 times
Medicare patients
744vs 1435.2 times
Part D claims
580vs 1184.9 times

Medians across 124 medical oncologists in Maryland with Dmand AI profiles that report each measure.

Dr. Murali's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Murali

Need commercial claims for Dr. Murali?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Murali and other medical oncologists in Maryland.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Shruti Murali treated 744 Medicare patients in 2024, average age 77

CMS counts 744 Medicare patients who saw Dr. Murali in 2024. The largest group is 75 to 84, with 320 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Murali's median patient age at 61, with 75% women.

Medicare patients, 2024744
Average age77
Average risk score1.75
Also on Medicaid10%

Dr. Murali's Medicare patients by age, 2024

Dr. Murali's Medicare patients by sex, 2024

  • Women46062%
  • Men28438%

Chronic conditions among Dr. Murali's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Cancer47%
  4. Arthritis45%
  5. Diabetes32%
  6. Chronic kidney disease31%
  7. Mood disorders27%
  8. Ischemic heart disease26%

Share of Medicare patients with each condition. A patient can have several.

Dr. Murali's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 61

Patient panel by sex, all payers

  • Women75%
  • Men23%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Shruti Murali wrote 805 Medicare Part D claims in 2024

In 2024, Dr. Murali wrote 805 Medicare Part D claims for 153 patients. 74% of them were for generic drugs. CMS names the drug for 580 of them, across 22 drugs with 11 or more claims each, at $1,887,081 in total drug cost. In 2023, CMS named 283 claims across 13 drugs.

Part D claims, 2024805
Drugs named by CMS22
Total drug cost$1.9M
Part D patients153

Dr. Murali's Part D claims by kind of drug, 2024

  • Generic599 claims74%
  • Brand-name206 claims26%

Dr. Murali's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Murali's Part D claims, 2024

  • Opioids3%22 of 805 claims
  • Antibiotics2%20 of 805 claims
  • Antipsychotics, patients 65 and over1%11 of 805 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2832024: 580105%

Drugs named by CMS: 22 in 2024, 13 in 2023.

See all prescribing by Dr. Murali

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Shruti Murali scored 93 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Murali for performance year 2024, reported individually. Dr. Murali accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Murali as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Murali's MIPS scores, performance year 2024

  • 93of 100Final score
  • 81.6of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Murali by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Shruti Murali has 3 publications on record

Dmand AI links 3 papers to Dr. Murali, published from 2016 to 2020. Dr. Murali's most frequent co-authors are Constantin Dasanu, MD, PhD, Juliana Alvarez Argote, MD and Emily Bellavance, MD.

Papers3
Years published2016 to 2020

Dr. Murali's most frequent co-authors

Recent publications by Dr. Murali

See all 3 publications and co-authors

See who Dr. Murali researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Murali works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Shruti Murali has worked on 1 clinical trial

Dmand AI links Dr. Murali to 1 clinical trial. 1 is still active or recruiting.

Investigators on the most trials with Dr. Murali

Recent clinical trials with Dr. Murali

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Shruti Murali received $4,649 in industry payments from 2017 to 2025

CMS Open Payments shows 141 general payments to Dr. Murali from 37 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 98% of the total. Genentech, Inc. paid the most, $830.

General payments to Dr. Murali by program year, 2017 to 2025

General payments to Dr. Murali by kind, 2017 to 2025

$4.6Kin total
  • Food and beverage$4,55898%
  • Education$922%

Companies that paid Dr. Murali the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Murali

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Shruti Murali's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Shruti Murali

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Shruti Murali's NPI number?

Dr. Shruti Murali's NPI number is 1902241649. It was assigned on May 8, 2013, and it is active in the NPI Registry.

What kind of doctor is Dr. Shruti Murali?

Dr. Shruti Murali is a medical oncologist in Rockville, Maryland. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Shruti Murali practice?

Dr. Murali practices at 9905 Medical Center Way, Rockville, MD 20850. Dr. Murali's primary practice is Maryland Oncology Hematology, P.A. in Rockville, Maryland. Dmand AI also links Dr. Murali to 4 hospitals, 2 group practices and clinics and 1 medical group.

What is Dr. Shruti Murali's office phone number?

The practice phone on file for Dr. Murali is (301) 470-1001.

What is Dr. Shruti Murali's medical license number?

Dr. Murali holds Maryland license D86774.

Which hospitals is Dr. Shruti Murali affiliated with?

Dr. Murali is affiliated with Adventist HealthCare Shady Grove Medical Center. Dmand AI links Dr. Murali to 4 more hospitals.

What medical group is Dr. Shruti Murali part of?

Dr. Murali is linked to UM St. Joseph Medical Group. Dmand AI links Dr. Murali to 1 more medical group.

Does Dr. Shruti Murali accept Medicare?

Yes. CMS data shows Dr. Murali billed Medicare for 152,801 services in 2024, and Dr. Murali accepts Medicare assignment.

Does Dr. Shruti Murali offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Murali as offering telehealth services.

What is Dr. Shruti Murali's MIPS score?

Dr. Murali's MIPS final score for performance year 2024 is 93 out of 100, reported individually.

Show 7 more questionsShow fewer questions

How many Medicare patients does Dr. Shruti Murali see?

CMS counts 744 Medicare patients who saw Dr. Murali in 2024, with an average age of 77.

What services does Dr. Shruti Murali bill to Medicare?

In 2024, Dr. Murali's most billed Medicare services were injected or infused drug (J0881), injected or infused drug (J9271) and injected or infused drug (J9144).

What drugs does Dr. Shruti Murali prescribe most?

In 2024 Medicare Part D data, Dr. Murali's most prescribed drugs by claims were Prednisone, Anastrozole and Letrozole.

Has Dr. Shruti Murali received payments from drug or device companies?

CMS Open Payments shows $4,649 in general payments to Dr. Murali from 37 companies from 2017 to 2025. The largest total came from Genentech, Inc.

How long has Dr. Shruti Murali been practicing?

Dr. Murali graduated from medical school in 2019, 7 years ago.

Does Dr. Shruti Murali do research?

Dmand AI links 3 publications to Dr. Murali, published from 2016 to 2020. Dr. Murali has worked on 1 clinical trial.

Who does Dr. Shruti Murali publish with?

Dr. Murali's most frequent co-authors are Constantin Dasanu, MD, PhD (2 shared papers), Juliana Alvarez Argote, MD (1 shared paper) and Emily Bellavance, MD (1 shared paper).

Selling to medical oncology practices?

See medical oncologists in Maryland by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)